Показано 0 из 0
Дата |
---|
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
19.04.2024 |
18.04.2024 |
17.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
1.665
|
1.995
|
1.98
|
1.70
|
2.05
|
1.995
|
|
1.88
|
16 610.61
|
16.00
|
1.85
|
1.975
|
1.85
|
1.845
|
2.05
|
1.98
|
|
1.94
|
82 579.59
|
26.00
|
1.745
|
1.835
|
1.96
|
1.745
|
1.96
|
1.84
|
|
1.84
|
23 239.17
|
9.00
|
1.60
|
1.96
|
1.58
|
1.575
|
2.00
|
1.96
|
|
1.66
|
37 312.55
|
22.00
|
1.435
|
1.575
|
1.45
|
1.425
|
1.60
|
1.58
|
|
1.48
|
6 424.43
|
11.00
|
1.42
|
1.45
|
1.50
|
1.40
|
1.50
|
1.45
|
|
1.45
|
38 140.44
|
26.00
|
1.45
|
1.50
|
1.43
|
1.43
|
1.50
|
1.50
|
|
1.50
|
25 616.08
|
18.00
|
1.455
|
1.55
|
1.59
|
1.545
|
1.59
|
1.56
|
|
1.55
|
29 671.20
|
16.00
|
1.505
|
1.595
|
1.64
|
1.525
|
1.64
|
1.595
|
|
1.60
|
27 498.92
|
12.00
|
1.58
|
1.645
|
1.73
|
1.495
|
1.73
|
1.685
|
|
1.55
|
44 876.92
|
26.00
|
Gabather AB is engaged in developing novel drugs to treat several diseases originating in the central nervous system. It has four main focus areas anti-psychotics, anti-depressants and anxiolytics, analgesics, as well as cognition-enhancing treatments, including for Alzheimer's disease.